NovaBridge Biosciences (NBP)

NovaBridge Biosciences (NBP) is a healthcare company (biotechnology) based in the United States. The share price is $0.77, down 2.70% on the day, which values the company at $89.33M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$0.77−2.70% today
Market value
$89.33M
200-week average
$2.2365% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

NovaBridge Biosciences in more detail

NBP trades at -0.6× next year's expected earnings. It sits 65% below its 200-week average of $2.23.

In its favour: More cash than debt. Worth checking: Weak Piotroski score.

1 of the superinvestors tracked here hold NBP, including Zhang Lei (1.4% of the portfolio).

Superinvestors holding NBP

1 of the investors tracked here report a position in their latest 13F filing.

NovaBridge Biosciences (NBP): questions and answers

What is NovaBridge Biosciences's market cap?

NovaBridge Biosciences is valued at $89.33M at a share price of $0.77.

Is NBP above its 200-week moving average?

No. NBP is 65.4% below its 200-week average of $2.23. Long-term investors watch that line because strong companies rarely trade below it for long.

Does NBP pay a dividend?

NovaBridge Biosciences does not currently pay a regular dividend.

Which famous investors own NBP?

In their latest quarterly filings, Zhang Lei (1.4% of the portfolio) hold NBP. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “NovaBridge Biosciences (NBP) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/NBP

Underlying data: Yahoo Finance; company filings with the SEC.